NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
RDHL
RedHill Biopharma Ltd.
There isn't enough reported data to score RDHL yet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RDHL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
RDHL's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
RDHL PE Valuation
RDHL has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
RDHL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect RDHL's losses to shrink, with revenue growing.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over RDHL in the latest year-over-year earnings comparison.
RDHL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | $0.25 | +$120.25 |
| Q2 2023 | -$59.00 | +$99.35 |
| Q4 2022 | -$120.00 | +$98.35 |
| Q2 2020 | -$300.00 | -$153.15 |
| Q4 2019 | -$280.00 | -$103.15 |
| Q4 2018 | -$176.85 | +$83.15 |
| Q4 2017 | -$260.00 | +$890.00 |
RDHL has returned to profit: it earned $0.25 per share over the past year, after losing money the year before.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over RDHL in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO's operating margin was 34% last quarter, down 9 points from the same quarter a year ago, near the bottom of its range since 2019.
RDHL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $4.1M | +59% |
| Q4 2024 | $5.5M | +382% |
| Q2 2024 | $2.6M | -52% |
| Q4 2023 | $1.1M | -96% |
| Q2 2023 | $5.4M | -83% |
| Q4 2022 | $30.4M | -31% |
| Q2 2022 | $31.5M | -25% |
| Q4 2021 | $43.7M | +3% |
RDHL's revenue has slid since its 2021 peak: $4M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -107% | -565 points |
| Q4 2024 | -113% | -57 points |
| Q2 2024 | -328% | -247 points |
| Q4 2023 | -1061% | -974 points |
| Q2 2023 | 457% | +560 points |
| Q4 2022 | -56% | +24 points |
| Q2 2022 | -82% | +52 points |
| Q4 2021 | -87% | +635 points |
RDHL's operating margin was −107% last quarter, down 565 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
RDHL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$5M | +$1.2M |
| Q4 2024 | -$3.2M | +$14.9M |
| Q2 2024 | -$6.2M | +$11.6M |
| Q4 2023 | -$18M | -$9.6M |
| Q2 2023 | -$17.8M | +$3.1M |
| Q4 2022 | -$8.5M | +$25.4M |
| Q2 2022 | -$20.9M | +$10.3M |
| Q4 2021 | -$33.9M | -$11.8M |
RDHL has burned cash in almost every quarter: −$32M over the past year, against −$81M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over RDHL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
RDHL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9252% | +50.6M shares |
| 1 year | +13933% | +50.8M shares |
| 3 years | +200407% | +51.1M shares |
RDHL has 51M diluted shares, up 13933% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2016 | — |
| Q3 2016 | — |
| Q2 2016 | — |
| Q1 2016 | — |
| Q4 2015 | — |
| Q3 2015 | — |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
RDHL Net Leverage
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
RDHL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.9 | Neutral |
| Stochastic | 2.1 | Oversold |
RDHL's weekly RSI is 31 (neutral) and its Stochastic is 2 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
RDHL PE vs Healthcare Sector
RDHL has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over RDHL on trend strength, trading above more of its moving averages.
RDHL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.45 | 16% below |
| 20 week MA | $0.58 | 34% below |
| 50 week MA | $0.84 | 55% below |
| 100 week MA | $1.75 | 78% below |
| 200 week MA | $20.6 | 98% below |
RDHL is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over RDHL on returns for 2026, with the stronger performance.
RDHL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,050.0 | $9,320.0 | +54% |
| 2021 | $9,320.0 | $2,640.0 | -72% |
| 2022 | $2,640.0 | $158.5 | -94% |
| 2023 | $158.5 | $36.5 | -77% |
| 2024 | $36.5 | $6.91 | -81% |
| 2025 | $6.91 | $1.14 | -84% |
| 2026 YTD | $1.14 | $0.38 | -67% |
RDHL has finished five years in a row lower, and it's down 67% so far in 2026.